ATE141167T1 - Hemmung der abstossung bei allogener und concordanter xenogener transplantation - Google Patents

Hemmung der abstossung bei allogener und concordanter xenogener transplantation

Info

Publication number
ATE141167T1
ATE141167T1 AT91907303T AT91907303T ATE141167T1 AT E141167 T1 ATE141167 T1 AT E141167T1 AT 91907303 T AT91907303 T AT 91907303T AT 91907303 T AT91907303 T AT 91907303T AT E141167 T1 ATE141167 T1 AT E141167T1
Authority
AT
Austria
Prior art keywords
rejection
concordant
xenogene
allogene
transplantation
Prior art date
Application number
AT91907303T
Other languages
English (en)
Inventor
David James Graham White
Den Bogaerde Johan Beyers Van
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutran Ltd filed Critical Imutran Ltd
Application granted granted Critical
Publication of ATE141167T1 publication Critical patent/ATE141167T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91907303T 1990-04-09 1991-04-04 Hemmung der abstossung bei allogener und concordanter xenogener transplantation ATE141167T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE141167T1 true ATE141167T1 (de) 1996-08-15

Family

ID=10674123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91907303T ATE141167T1 (de) 1990-04-09 1991-04-04 Hemmung der abstossung bei allogener und concordanter xenogener transplantation

Country Status (22)

Country Link
EP (1) EP0527762B1 (de)
JP (1) JP3518547B2 (de)
CN (1) CN1040178C (de)
AT (1) ATE141167T1 (de)
AU (1) AU7555591A (de)
CZ (1) CZ283119B6 (de)
DE (1) DE69121401T2 (de)
DK (1) DK0527762T3 (de)
ES (1) ES2090325T3 (de)
GB (1) GB9007971D0 (de)
GR (1) GR3021642T3 (de)
HK (1) HK48597A (de)
IE (1) IE911153A1 (de)
IL (1) IL97788A (de)
IN (1) IN173149B (de)
MY (1) MY106158A (de)
NZ (1) NZ237739A (de)
PT (1) PT97277B (de)
SG (1) SG47465A1 (de)
SK (1) SK279949B6 (de)
WO (1) WO1991015221A1 (de)
ZA (1) ZA912467B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60020727T2 (de) 1999-10-27 2006-05-04 Robert London Zhong Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
AU2001291579B2 (en) * 2000-09-29 2006-08-31 Viron Therapeutics Inc. Use of serp- 1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
EP2338511A3 (de) * 2004-05-14 2012-07-25 Alexion Pharmaceuticals, Inc. Verlängerung der Überlebungszeit eines Allografts durch Hemmung der Komplementsaktivität
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
EP2073898A1 (de) 2006-10-10 2009-07-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Komplementhemmung für verbesserte nervenregeneration
CA2742802C (en) 2008-11-10 2019-11-26 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
SI3011345T1 (sl) 2013-08-07 2017-12-29 Alexion Pharmaceuticals, Inc. Biomarkerski proteini za atipični hemolitični uremični sindrom (ahus)

Also Published As

Publication number Publication date
CN1056240A (zh) 1991-11-20
ES2090325T3 (es) 1996-10-16
HK48597A (en) 1997-04-25
PT97277B (pt) 1998-08-31
WO1991015221A1 (en) 1991-10-17
DE69121401D1 (de) 1996-09-19
CS9100988A2 (en) 1991-12-17
DK0527762T3 (da) 1996-09-02
PT97277A (pt) 1992-01-31
AU7555591A (en) 1991-10-30
SK279949B6 (sk) 1999-06-11
IL97788A (en) 1998-02-08
DE69121401T2 (de) 1996-12-12
CZ283119B6 (cs) 1998-01-14
NZ237739A (en) 1993-09-27
ZA912467B (en) 1992-12-30
GB9007971D0 (en) 1990-06-06
IL97788A0 (en) 1992-06-21
JPH05507266A (ja) 1993-10-21
MY106158A (en) 1995-03-31
GR3021642T3 (en) 1997-02-28
IE911153A1 (en) 1991-10-09
SG47465A1 (en) 1998-04-17
EP0527762A1 (de) 1993-02-24
IN173149B (de) 1994-02-19
CN1040178C (zh) 1998-10-14
JP3518547B2 (ja) 2004-04-12
EP0527762B1 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
ES2085299T3 (es) Uso de rapamicina y sus derivados y profarmacos en la fabricacion de un medicamento para inhibir el rechazo de los transplantes en los mamiferos.
ATE71298T1 (de) Immunoregulation.
NO961345L (no) O-aryl, O-alkyl-, O-alkenyl- og O-alkynylmakrolider med immunundertrykkende aktivitet
ES2099158T3 (es) Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
BG96329A (bg) Модифициран биологичен материал
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
ES2111615T3 (es) Imidazolidil macrolidos con actividad inmunosupresora.
ATE165511T1 (de) Behandlung von organtransplantatsabstossung
ATE141167T1 (de) Hemmung der abstossung bei allogener und concordanter xenogener transplantation
EP0484071A3 (en) Synergism of hiv reverse transcriptase inhibitors
NO20035434D0 (no) Behandling eller profylakse av transplantasjonsavst degree tning av insulinproduserende celler
ES2055415T3 (es) S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas.
DE69835965D1 (de) CD154-BLOCKADETHERAPIE DER PANKREASINSELZELLTRANSPLANTATION bei Primaten
ATE144536T1 (de) Cyclosporin- derivate
ES2065698T3 (es) Autobioticos y su utilizacion para eliminar in vivo celulas extrañas.
DK490486D0 (da) Sammensaetning til behandling af atherosclerose, tromboser og/eller perifere karsygdomme
NO2019032I1 (no) Treosulfan
ES2053942T3 (es) Empleo de aductos de oxido de 1,2-butileno en compuestos organicos h-azidas como lubricantes y lubricantes que contienen estos aductos.
FI952018A7 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskri ptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
TH13234A (th) การยับยั้งปฏิกิริยาที่ไม่ยอมรับเนื้อเยื่อที่ปลูกของส่วนปลูกตอนต่อของสมาชิกพันธุ์เดียวกัน และส่วนปลูกตอนต่อของพันธุ์ที่แตกต่างกัน แต่กลมกลืนกัน
DK376587A (da) Methylenchloridbaseret middel til anvendelse ved affedtning af metaller
TH8957B (th) การยับยั้งปฏิกิริยาที่ไม่ยอมรับเนื้อเยื่อที่ปลูกของส่วนปลูกตอนต่อของสมาชิกพันธุ์เดียวกัน และส่วนปลูกตอนต่อของพันธุ์ที่แตกต่างกัน แต่กลมกลืนกัน
TR26443A (tr) TOPRAK VE/VEYA DOGAL GAZ ISLEME TECHIZATININ KIRLILIGINI GIDERME USULü.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee